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Glycerol monolaurate inhibits lipase production by clinical ocular isolates without 
affecting bacterial cell viability 
Abstract 
PURPOSE. We sought to determine the relative lipase production of a range of ocular bacterial isolates 
and to assess the efficacy of glycerol monolaurate (GML) in inhibiting this lipase production in high 
lipase-producing bacteria without affecting bacterial cell growth. METHODS. Staphylococcus aureus, 
Staphylococcus epidermidis, Propionibacterium acnes, and Corynebacterium spp. were inoculated at a 
density of 106/mL in varying concentrations of GML up to 25 μg/mL for 24 hours at 378C with constant 
shaking. Bacterial suspensions were centrifuged, bacterial cell density was determined, and production of 
bacterial lipase was quantified using a commercial lipase assay kit. RESULTS. Staphylococcus spp. 
produced high levels of lipase activity compared with P. acnes and Corynebacterium spp. GML inhibited 
lipase production by Staphylococcal spp. in a dosedependent manner, with S. epidermidis lipase 
production consistently more sensitive to GML than S. aureus. Glycerol monolaurate showed significant 
(P < 0.05) lipase inhibition above concentrations of 15 μg /mL in S. aureus and was not cytotoxic up to 25 
μg /mL. For S. epidermidis, GML showed significant (P < 0.05) lipase inhibition above 7.5 μg /mL. 
CONCLUSIONS. Lipase activity varied between species and between strains. Staphylococcal spp. 
produced higher lipase activity compared with P. acnes and Corynebacterium spp. Glycerol monolaurate 
inhibited lipase production by S. aureus and S. epidermidis at concentrations that did not adversely affect 
bacterial cell growth. GML can be used to inhibit ocular bacterial lipase production without proving 
detrimental to commensal bacteria viability. 
Keywords 





Flanagan, J. Louise., Khandekar, N., Zhu, H., Watanabe, K., Markoulli, M., Flanagan, J. Terence. & Papas, E. 
(2016). Glycerol monolaurate inhibits lipase production by clinical ocular isolates without affecting 
bacterial cell viability. Investigative Ophthalmology and Visual Science, 57 (2), 544-550. 
Authors 
Judith Louise Flanagan, Neeta Khandekar, Hua Zhu, Keizo Watanabe, Maria Markoulli, John T. Flanagan, 
and Eric B. Papas 
This journal article is available at Research Online: https://ro.uow.edu.au/gsbpapers/454 
Cornea
Glycerol Monolaurate Inhibits Lipase Production by
Clinical Ocular Isolates Without Affecting Bacterial Cell
Viability
Judith Louise Flanagan,1,2 Neeta Khandekar,1 Hua Zhu,1–3 Keizo Watanabe,4 Maria Markoulli,2
John Terence Flanagan,5 and Eric Papas1–3
1Brien Holden Vision Institute, Sydney, Australia
2School of Optometry and Vision Science, University of New South Wales, Sydney, Australia
3Vision Cooperative Research Centre, Sydney, Australia
4Kinki University School of Medicine, Osaka, Japan
5Sydney Business School, University of Wollongong, Wollongong, Australia
Correspondence: Judith Louise Fla-
nagan, Level 3 Rupert Myers Build-
ing, University of New South Wales,
Sydney, NSW 2052, Australia;
j.flanagan@brienholdenvision.org.
Submitted: April 28, 2015
Accepted: January 12, 2016
Citation: Flanagan JL, Khandekar N,
Zhu H, et al. Glycerol monolaurate
inhibits lipase production by clinical
ocular isolates without affecting bac-
terial cell viability. Invest Ophthalmol
Vis Sci. 2016;57:544–550.
DOI:10.1167/iovs.15-17180
PURPOSE. We sought to determine the relative lipase production of a range of ocular bacterial
isolates and to assess the efficacy of glycerol monolaurate (GML) in inhibiting this lipase
production in high lipase–producing bacteria without affecting bacterial cell growth.
METHODS. Staphylococcus aureus, Staphylococcus epidermidis, Propionibacterium acnes,
and Corynebacterium spp. were inoculated at a density of 106/mL in varying concentrations
of GML up to 25 lg/mL for 24 hours at 378C with constant shaking. Bacterial suspensions
were centrifuged, bacterial cell density was determined, and production of bacterial lipase
was quantified using a commercial lipase assay kit.
RESULTS. Staphylococcus spp. produced high levels of lipase activity compared with P. acnes
and Corynebacterium spp. GML inhibited lipase production by Staphylococcal spp. in a dose-
dependent manner, with S. epidermidis lipase production consistently more sensitive to GML
than S. aureus. Glycerol monolaurate showed significant (P < 0.05) lipase inhibition above
concentrations of 15 lg/mL in S. aureus and was not cytotoxic up to 25 lg/mL. For S.
epidermidis, GML showed significant (P < 0.05) lipase inhibition above 7.5 lg/mL.
CONCLUSIONS. Lipase activity varied between species and between strains. Staphylococcal spp.
produced higher lipase activity compared with P. acnes and Corynebacterium spp. Glycerol
monolaurate inhibited lipase production by S. aureus and S. epidermidis at concentrations
that did not adversely affect bacterial cell growth. GML can be used to inhibit ocular bacterial
lipase production without proving detrimental to commensal bacteria viability.
Keywords: bacterial lipase, dry eye, microbiome
Dry eye is one of the least well-defined disorders of theocular surface, with characterization, prevalence, and
etiology constantly reassessed in the literature. In 2007, the
International Workshop on Dry Eye adopted the concept of dry
eye disease as a multifactorial disease of the tears and ocular
surface accompanied by increased osmolarity of the tear film
and inflammation of the ocular surface.1 Meibomian gland
dysfunction (MGD) is believed to play a leading role in the
development of dry eye and has been suggested as the leading
cause of this disorder.2 The consensus definition of MGD
encompasses terminal gland obstruction and alterations of the
tear film, clinically apparent inflammation, and ocular surface
disease.2
The pathophysiology of MGD is complex, and the role of
bacteria or parasites in the etiology of MGD remains
controversial. It is well known that commensal bacteria such
as Staphylococcus epidermidis, Staphylococcus aureus,
Corynebacterium spp., and Propionibacterium acnes are
associated with, and contribute to, the pathologic course of
chronic blepharitis, but to date no reports implicate bacteria
in the primary pathologic process of MGD.3 Paralleling the
rising interest in the human microbiome in health and
disease,4 the role of microbial flora in ocular health and
disease is beginning to be appreciated.5 Quorum sensing has
been implicated in perturbation of the ocular microbiome (as
cause or effect of an altered eye lid microbial environment),
leading to a pathologic imbalance of commensal bacteria.6
This imbalance can trigger release of exotoxins, lipopolysac-
charides, and lipase activation, causing eyelid inflammation
and lipidic changes (including the release of free fatty acids),
leading to reduced tear film stability.6
Bacterial lipases can alter tear lipids, leading to increased
cytokine expression and inflammation associated with dry eye
disease. Numerous studies7–10 have reported the benefit of
tetracycline and its analogues in treating meibomianitis and
blepharitis, demonstrating a persistent reduction in S. aureus
and S. epidermidis colonization after 3 months. Tetracyclines
are primarily used in MGD treatment for their anti-inflammatory
and lipid-regulating effects.11 However, long-term use of
antibiotics has deleterious side effects including emergence of
resistance and elimination of commensal bacteria that can lead
to undesirable side effects resulting from the collapse of the
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eye’s own immunodefense system.12 The present study
explores the potential of a compound that, in the absence of
biocidal activity, inhibits bacterial lipases that can alter tear
lipids.
Generally recognized as safe by the US Food and Drug
Administration for topical use at doses up to 100 mg/mL,13
glycerol monolaurate (GML) is a fatty acid monoester that has
long been used in the food and cosmetics industries as an
emulsifier and preservative.14 At concentrations lower than
those required for biocidal action, GML blocks bacterial release
of virulence factors including bacterial lipase.15
We sought to determine lipase production in a range of
Staphylococcus spp., P. acnes, and Corynebacterium spp.
ocular isolates and to characterize the inhibitory actions of
GML on bacterial lipase production in the absence of biocidal
activity.16 We found that lipase production varies in a species-
and strain-specific manner and that GML can inhibit lipase
production without affecting bacterial cell viability.
MATERIALS AND METHODS
Chemicals
Glycerol monolaurate was purchased from (Corden Pharma Pty
Ltd., Liestal, Switzerland) and dissolved in 100% ethanol to a
final stock concentration of 200 mg/mL and stored at208C.
Growth of Bacterial Strains
In total, clinical isolates primarily comprising ocular commen-
sal species were examined. These included 37 isolates of
Staphylococcus aureus, 31 of Staphylococcus epidermidis, 25
isolates of Propionibacteria acnes, and 8 of Corynebacterium
spp. regrown from frozen stocks on chocolate agar for 24
hours in an ambient air incubator or, for P. acnes, an anaerobic
jar at 378C.
Production of Bacterial Lipases
Single colonies were inoculated into 10 mL tryptone soy broth
(TSB; Oxiod, Thermo Fisher Scientific Australia Pty Ltd.,
Adelaide SA, Australia) and incubated under the appropriate
conditions. After 24 hours, OD660nm was measured to assess
bacterial growth. Extracellular lipase enzymes in the superna-
tant were separated from bacterial cells by centrifugation
(956g, 10 minutes). Supernatants were collected and filtered
through a 0.22-lm filter to remove any residual bacterial cells
and stored at 208C till further use.
Analyzing Lipase Activity
Lipase activity in culture supernatant (as a measure of lipase
production) was quantified using a commercially available kit
(QuantiChrom Lipase Assay Kit; BioAssay Systems, Hayward,
CA, USA). The colorimetric assay was performed as per
manufacturer’s instructions. Lipase activity was measured in
units per liter.
Lipase Enzymic Activity in the Presence of GML
Staphylococcus aureus 020 was streaked on chocolate agar
plates and incubated at 378C for 24 hours. Resulting colonies
were inoculated into 3 mL TSB and incubated at 378C for 24
hours. Resulting bacterial suspensions were centrifuged to
collect supernatant (containing lipases). These fractions were
then filtered through a 0.22-lm filter to remove contaminating
cell debris. To this ‘‘conditioned’’ supernatant was added GML
up to 500 lg/mL. These supernatant þ GML fractions were
incubated 24 hours at 378C. Lipase assay detection was
performed as described above. Control comprised filtered
bacterial supernatant from S. aureus 020 was grown overnight
in the presence of GML (20 lg/mL) and similarly assayed for
lipase activity.
GML Inhibition of Bacterial Lipase Production
Two S. aureus and two S. epidermidis isolates with the highest
lipase activities were selected and grown for 24 hours at 378C
in the presence or absence of GML (0–25 lg/mL) diluted in
TSB. Lipase production (measured as lipase activity) was
quantitated as above.
Statistical Analysis
The Kolmogorov-Smirnov test and the Shapiro-Wilk test were
used to test for normality of lipase production between isolates
of S. aureus, S. epidermidis, P. acnes, and Corynebacterium
spp. To overcome limitations due to determined nonnormality
or small sample size, bootstrapping (Statistical Package for
Social Sciences; http://www-01.ibm.com/software/analytics/
spss/products/statistics/) was used to obtain unbiased esti-
mates of 95% confidence intervals for the population median.
Significant differences in lipase production of each of the four
groups was determined using the nonparametric test of Oyeka
and Okeh.17 This test is based on the statistic Q calculated from
the ranks of items in the combined sample of size n ¼ n1þn2








where Ri is the sum of ranks in the combined sample of items
from sample i, and Q is asymptotically v2 distributed with one
degree of freedom.
Lipase inhibition results are presented as mean 6 SD. The
Student’s t-test was performed for comparison of data
comprising two groups at the P < 0.05 level of significance.
RESULTS
Bacterial Lipase Production
Levels of bacterial cell lipase production varied between
species and within strains (Fig. 1). Because the distribution of
lipase activities is positively skewed (Fig. 1) as determined by
the Kolmogorov-Smirnov and Shapiro-Wilk tests, to determine
significant differences in lipase production, we compared
median lipase production (lower and upper 95% confidence
limits, respectively; Fig. 2). Potential outliers as identified in the
boxplot were included in our analysis as a more conservative
test for significant differences because, as discussed by Hubert
and Vandervieren,18 the SPSS Boxplot procedure is based on
the tacit assumption that the data are drawn from a normal
distribution and, in the case of positively skewed distributions
(as our data are), typically misclassifies approximately 8% of
the higher end values as possible outliers.
Median lipase production for S. aureus was significantly
different to medians of S. epidermidis, P. acnes, and
Corynebacterium spp. Median lipase production for S.
epidermidis was similarly significantly different to median
production for each of the other bacterial groups tested (Fig.
2). The difference in median lipase production for P. acnes and
Corynebacterium spp. did not reach significance. Similarly,
median lipase production was highest in S. aureus, followed by
S. epidermidis isolates, P. acnes, and Corynebacterium spp.,
Glycerol Monolaurate Inhibits Bacterial Lipase Production IOVS j February 2016 j Vol. 57 j No. 2 j 545
Downloaded From: http://arvojournals.org/ on 06/13/2016
respectively. Lipase production by Staphylococcus spp. was
generally much higher than that of P. acnes and Corynebac-
terium spp. isolates. Because lipase production by P. acnes and
Cornyebacterium spp. was minimal, none of these isolates
were tested further.
Determination of Lipase Enzyme Stability in the
Presence of GML
We sought to determine the mode of action of GML: whether
inhibition of lipase production or inhibition of lipase activity
(Fig. 3). In the presence of conditioned supernatant containing
bacterially expressed lipase from overnight cultures (S. aureus
020), increasing concentrations of GML had no inhibitory
effect on lipase activity. This is in stark contrast to the
inhibition of lipase production evident in the bacteria control
in which S. aureus was grown overnight in the presence of
GML (20 lg/mL). That there was little lipase activity detected
when S. aureus was grown in the presence of GML compared
with the lipase activity remaining in the supernatants
containing expressed lipase incubated with GML illustrates
the mechanism of action of GML resides in inhibition of
production rather than inhibition of lipase activity per se.
GML Inhibition of Bacterial Growth
Bacterial toxicity of GML was titrated to determine the
bacteriocidal threshold. We chose to monitor the bacteriocidal
activity of increasing concentrations of GML on the two
highest lipase producing isolates from S. aureus and S.
epidermidis, respectively: S. aureus 020 and 134, and S.
epidermidis 001 and 024. We observed that growth of both
clinical isolates of S. aureus remained unaffected in the
presence of GML up to 25 lg/mL (Fig. 4A). Staphylococcus
epidermidis exhibited a strain-dependent sensitivity to the
growth inhibition of GML, with S. epidermidis 024 exhibiting a
slight decline in growth when incubated in concentrations of
GML greater than 15 lg/mL (Fig. 4B).
Effect of Varying Concentrations of GML on
Bacterial Lipase Production
Glycerol monolaurate exerted a dose-dependent inhibition of
bacterial lipase production by S. aureus 020 and 134 (Fig. 4A)
and S. epidermidis 001 and 024 (Fig. 4B). Glycerol mono-
laurate concentrations of 15 lg/mL and above induced
significant (P < 0.05) inhibition of lipase production by both
FIGURE 1. Lipase activity histograms showing distribution of lipase production in clinical isolates (A) S. aureus, (B) S. epidermidis, (C) P. acnes, and
(D) Corynebacterium spp.
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S. aureus strains; lipases were reduced by approximately 60%
in the presence of GML at 15 lg/mL and almost 90% at 25 lg/
mL GML.
Staphylococcus epidermidis lipase production was consis-
tently more sensitive to GML than were S. aureus isolates.
Glycerol monolaurate at 10 lg/mL for S. epidermidis 001 and
as low as 5 lg/mL for S. epidermidis 024 significantly (P <
0.05) reduced bacterial lipase production relative to no GML.
The lipase inhibition was concentration dependent for both
strains.
DISCUSSION
Lipase production activities were determined for S. aureus,
coagulase-negative staphylococci, P. acnes, and Corynebacterium
spp. The level of bacterial lipase activity varied widely between
the ocular species and strains examined: P. acnes and Coryne-
bacterium spp. produced relatively low lipase activity, whereas
the Staphylococcus spp. produced relatively high lipase activities.
The finding of low lipase production by P. acnes and
Corynebacterium spp. is interesting in light of evidence from
Lee et al.19 that, in blepharitis subjects, the relative abundance
of P. acnes in the ocular microbiome was decreased compared
with healthy subjects, whereas that of Staphylococcus spp.
was increased. In an earlier study,20 Corynebacterium spp.
were more likely to be detected in patients suffering from
blepharitis who presented without dry eye than those
blepharitis patients with dry eye. The species we examined
in the present study are the most frequently isolated from
blepharitis patients.21
Our observations are consistent with the idea that a higher
proportion of low lipase producing bacteria might be
protective against tear film lipid degradation. Conversely, an
overrepresentation of high lipase–producing bacteria might
destabilize the tear film. In the present study, S. aureus and S.
epidermidis showed a divergent range of lipase activities, with
S. aureus generally exhibiting higher lipase activities than the
S. epidermidis isolates. It has been proposed that S.
epidermidis might have evolved not to cause disease but to
maintain a benign relationship with the host22 and further,
might play a probiotic role in preventing colonization by more
severe pathogens, such as S. aureus.23
Culture independent analyses of the ocular microbiome—in
contrast to the relatively low culturable bioburden on the
eye—are reporting a robust community of complex dynam-
ics.19 As with other regions of the body, microbial dysbiosis
characterized by shifts in populations and a loss of species
diversity—a feature of chronic disease24—can occur in the
ocular microbiome. How these communities shift in chronic
dry eye is a matter of great interest. Zegans and Van Gelder25
FIGURE 2. Lipase activity of clinical isolates. Box plot showing relative lipase activities of S. aureus, S. epidermidis, P. acnes, and Corynebacterium
spp. Lipase activity was determined as in Materials and Methods. * and # indicate significant difference P < 0.05 from each of the other groups.
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recently suggested that many idiopathic ocular disorders,
including dry eye disease, that are characterized by an
inflammatory component might be in part due to dysregulation
of the ocular microbiota and the concomitant release of
specific toxins or the triggering of a large immune response.
This is consistent with our hypothesis of the contribution of
dysregulation of lipase-producing commensal bacteria to the
etiology of dry eye disease. Staphylococcus epidermidis (a
ubiquitous constituent of commensal microflora26), along with
the more virulent S. aureus,22 can become opportunistic under
the appropriate conditions. Exploring dry eye disease in terms
of a tipping point in the ecologic balance of the ocular
microbiota might shed new light on this disorder. We
previously reported (Zhu H, et al. IOVS 2013;54:ARVO E-
Abstract 926) that in normal subjects (without dry eye or other
ocular disease), the average number of bacteria recovered from
eyes of younger females was lower than that of older females or
males and that this reduced bacterial burden correlated with
clinical measures of increased meibum quality and function.
Lipase inhibitors exert a specific bacteriostatic action on
Gram-positive bacteria through a delay in growth initiation and
a decrease in maximum growth achieved.27,28 Concentrations
at which GML was observed to inhibit growth are in keeping
with previous reports of minimal inhibitory concentrations
(between 10 and 63 lg/mL) of GML against S. aureus strains;
the magnitude of the range was ascribed to inherent strain
variation, inoculum size, and culture conditions.13,16,28,29
Bacterial lipases in growing culture can hydrolyze GML to
lauric acid.14 Lauric acid is more stable in the presence of
bacterial lipases and similarly inhibits staphylococcal exoprotein
production.14 In the skin, lauric acid is released from sebaceous
triglycerides through bacterial lipase action,30 acting to protect
against pathogens and drying. We speculate that a similar action
might occur in the tear film and meibomian triglycerides once
the meibum has been exposed to the ocular microbiota and that
a balanced presence of lipase producing S. epidermidis is part
of a healthy ocular environment. Bacteriostasis could check
overgrowth of opportunistic pathogens and help rebalance the
commensal microflora, producing sufficient lipase to effect a
steady concentration of lauric acid (as a product of hydrolysis of
meibum) while limiting deleterious lipase action on tear film
stability. In support of this, in 1982, Doughtery and McCulley31
reported significantly reduced amounts of C12:0 fatty acids in
mixed seborrheic/staphylococcal blepharitis and meibomian
seborrheic blepharitis compared with normals, whereas recent-
ly, Arita et al.32 reported the presence of C12:0 fatty acids in
meibum of dry eye patients and indicated a continual decrease
of this fatty acid species as meibum moved from clear to cloudy
to yellow, suggesting that healthier meibum is associated with
increased concentration of C12:0 fatty acids.
Tetracycline analogues have been used to treat dry eye
symptoms.8 The mechanism of action of these analogues in
treating meibomianitis is not yet fully elucidated; however,
tetracycline analogues are known to inhibit bacterial lipase
activity, inducing a concomitant reduction in free fatty acids
generated from hydrolysis of wax and sterol esters.10,33,34 As it
is well known that long-term use of antibiotics has deleterious
consequences including increased resistance and a potentially
catastrophic shift in the commensal flora, lipase inhibition in
the absence of antimicrobial action is preferable.
Use of GML to reduce virulence factors in toxic shock
syndrome has shown GML does not alter mucosal or microflora
integrity and stabilizes mammalian cell membranes leading to
reduced production of proinflammatory cytokines from
epithelial cells.35,36 As GML is safe for use on skin and mucosal
surfaces13 and is considered to be an ocular nonirritant,37 it
FIGURE 3. Stability of bacterial lipase enzyme activity in the presence of GML. Filtered supernatant from overnight cultures of S. aureus 020 grown
in the absence of GML was incubated with increasing concentrations of GML, and lipase activity was assessed. Control culture S. aureus 020 was
grown in the presence of GML (20 lg/mL), and lipase activity was similarly assessed.
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could potentially play a role in protecting against bacterially
mediated tear film instability.
The role of lipases in bacterial pathogenesis is incompletely
understood; however, these enzymes are thought to contribute
to overall fitness of the pathogens by providing a nutrition
source and releasing fatty acids to which the bacteria can
adhere.26,38 Additionally, S. epidermidis lipases appear to play a
role in limiting colonization by S. aureus, and S. aureus lipases
interfere with phagocytosis of S. aureus by granulocytes.39
Controlling lipase production that results from overgrowth of
opportunistic pathogens could reduce overall fitness of these
bacteria and assist in rebalancing the ocular microbiome.
Interestingly, Dave et al.40 provide evidence that efficacy of
azithromycin administration for blepharitis might not be due to
its antibacterial properties but more from the outcompeting of
S. aureus by S. epidermidis, suggesting that azithromycin
renders S. aureus ‘‘less fit’’ relative to S. epidermidis.
Application of GML to the ocular surface might similarly affect
the fitness of the higher lipase producer (S. aureus) relative to
that of S. epidermidis.
As eloquently expressed by Andersen et al.: ‘‘To study
bacterial cells, we must remove them from the host environ-
ment. . .which may release them from selective pressures that
we wish to understand.’’41 Bacterial virulence factors (includ-
ing S. aureus lipases) are regulated largely through quorum
sensing.42 As such, expression of virulence determinants in
isolated strains could differ substantially compared with
behaviors within the context of community.
Hence, a limitation of the present work is the determination
of bacterial lipase production by isolated strains. Because more
than 600 genera43 have been identified from conjunctiva of
healthy subjects, in vitro modeling of community interactions
would be extremely complex. Whole community shotgun
genomics or proteomics with in silico analysis of potential
community interactions could offer a powerful alternative.44,45
In addition, studying lipase production and the influence of
GML in the context of the dynamics of the in vivo bacterial
community is a natural extension of these investigations.
The significant finding in our study is that GML inhibits lipase
production by S. aureus and S. epidermidis at low concentra-
tions without adversely affecting bacterial cell growth and thus
potentially could be used in vivo to inhibit lipases produced by
ocular isolates without proving detrimental to commensal
bacteria, leading to a more stable tear film. Judicious choice of
a bacterial lipase inhibitor that protects the commensal ocular
flora could potentially reduce the progression of dry eye disease.
Improved understanding of the dynamics of the ocular micro-
biome in health and disease, including the role of bacterial
lipases and the action of GML in vivo, might add considerably to
our understanding of dry eye disease.
Acknowledgments
The authors thank Rani Bandara and Amali Ariyavidana for
excellent technical assistance.
Supported by the Brien Holden Vision Institute.
Disclosure: J.L. Flanagan, P; N. Khandekar, None; H. Zhu, P; K.
Watanabe, None; M. Markoulli, None; J.T. Flanagan, None; E.
Papas, None
References
1. Lemp MA, Baudouin C, Baum J, et al. The definition and
classification of dry eye disease: Report of the Definition and
Classification Subcommittee of the International Dry Eye
Workshop (2007). Ocul Surf. 2007;5:75–92.
2. Nichols KK, Foulks GN, Bron AJ, et al. The International
Workshop on Meibomian Gland Dysfunction: Executive
summary. Invest Ophthalmol Vis Sci. 2011;52:1922–1929.
3. Geerling G, Tauber J, Baudouin C, et al. The International
Workshop on Meibomian Gland Dysfunction: Report of the
Subcommittee on Management and Treatment of Meibomian
Gland Dysfunction. Invest Ophthalmol Vis Sci. 2011;52:2050–
2064.
4. Cho I, Blaser MJ. The human microbiome: At the interface of
health and disease. Nat Rev Genet. 2012;13:260–270.
5. Miller D, Iovieno A. The role of microbial flora on the ocular
surface. Curr Opin Allergy Clin Immunol. 2009;9:466–470.
6. Veldman P, Colby K. Current evidence for topical azithromycin
1% ophthalmic solution in the treatment of blepharitis and
blepharitis-associated ocular dryness. Int Ophthalmol Clinics.
2011;51:43–52.
7. Aronowicz JD, Shine WE, Oral D, Vargas JM, McCulley JP. Short
term oral minocycline treatment of meibomianitis. Br J
Ophthalmol. 2006;90:856–860.
FIGURE 4. Effect of increasing concentrations of GML on bacterial cell
viability and lipase production. (A) Glycerol monolaurate proved
nontoxic to S. aureus 020 and S. aureus 134 up to 25 lg/mL GML and
inhibited the bacterial lipases in a dose-dependent manner. * and #
indicate significant differences (P < 0.05) in the lipase production in
the presence of GML by S. aureus 020 and S. aureus 134, respectively,
compared with their lipase production in the absence of GML. & S.
aureus 020 & S. aureus 134 S. aureus 020 growth 3 S. aureus 134
growth. (B) Glycerol monolaurate was nontoxic to S. epidermidis 001
and 024 up to a concentration of 15 lg/mL. Glycerol monolaurate
inhibited the bacterial lipases in a dose-dependent manner. * and #
show significant differences (P < 0.05) in the lipase production in the
presence of GML by S. epidermidis 001 and S. epidermidis 024,
respectively, compared with their lipase production in the absence of
GML. & S. epidermidis 001 & S. epidermidis 024 S. epidermidis
001 growth 3 S. epidermidis 024 growth.
Glycerol Monolaurate Inhibits Bacterial Lipase Production IOVS j February 2016 j Vol. 57 j No. 2 j 549
Downloaded From: http://arvojournals.org/ on 06/13/2016
8. Dougherty JM, Mcculley JP, Silvany RE, Meyer DR. The role of
tetracycline in chronic blepharitis: Inhibition of lipase
production in Staphylococci. Invest Ophthalmol Vis Sci.
1991;32:2970–2975.
9. Shine WE, McCulley JP, Pandya AG. Minocycline effect on
meibomian gland lipids in meibomianitis patients. Exp Eye
Res. 2003;76:417–420.
10. Ta CN, Shine WE, McCulley JP, Pandya A, Trattler W, Norbury
JW. Effects of minocycline on the ocular flora of patients with
acne rosacea or seborrheic blepharitis. Cornea. 2003;22:545–
548.
11. Srinivasan S, Menzies KL, Sorbara L, Jones LW. Imaging
meibomian glands on a patient with chalazia in the upper
and lower lids: A case report. Contact Lens Anterior Eye.
2013;36:199–203.
12. Vanderlaan DG, Schultz CL, Brown-Skrobot SK, inventors;
Johnson & Johnson Vision Products, Inc., assignee. Ophthal-
mic Lens with Anti-Toxin Agent. US patent 5,472,703.
December 5, 1995.
13. Lin YC, Schlievert PM, Anderson MJ, et al. Glycerol mono-
laurate and dodecylglycerol effects on Staphylococcus aureus
and toxic shock syndrome toxin-1 in vitro and in vivo. PloS
One. 2009;4:e7499.
14. Ruzin A, Novick RP. Equivalence of lauric acid and glycerol
monolaurate as inhibitors of signal transduction in Staphylo-
coccus aureus. J Bacteriol. 2000;182:2668–2671.
15. Schlievert PM, Deringer JR, Kim MH, Projan SJ, Novick RP.
Effect of glycerol monolaurate on bacterial growth and toxin
production. Antimicrob Agents Chemother. 1992;36:626–
631.
16. Holland KT, Taylor D, Farrell AM. The effect of glycerol
monolaurate on growth of, and production of toxic shock
syndrome toxin-1 and lipase by, Staphylococcus aureus. J
Antimicrob Chemother. 1994;33:41–55.
17. Oyeka ICA, Okeh UMW. Statistic: Ties adjusted two sample
test. Open Access Sci. Rep. 2013;2:639.
18. Hubert M, Vandervieren E. An adjusted boxplot for skewed
distributions. Comput Stat Data Anal. 2008;52:5186–5201.
19. Lee SH, Oh DH, Jung JY, Kim JC, Jeon CO. Comparative ocular
microbial communities in humans with and without blepha-
ritis. Invest Ophthalmol Vis Sci. 2012;53:5585–5593.
20. Groden LR, Murphy B, Rodnite J, Genvert GI. Lid flora in
blepharitis. Cornea. 1991;10:50–53.
21. Doughety JM, McCulley JP. Comparative bacteriology of
chronic blepharitis. Br J Ophthalmol. 1984;68:524–528.
22. Otto M. Staphylococcus epidermidis: The ‘‘accidental’’
pathogen. Nature Rev Microbiol. 2009;7:555–567.
23. Lina G, Boutite F, Tristan A, Bes M, Etienne J, Vandenesch F.
Bacterial competition for human nasal cavity colonization:
Role of staphylococcal Agr alleles. Appl Environ Microbiol.
2003;69:18–23.
24. Kerr CA, Grice DM, Tran CD, et al. Early life events influence
whole-of-life metabolic health via gut microflora and gut
permeability. Crit Rev Microbiol. 2015;41:326–340.
25. Zegans ME, Van Gelder RN. Considerations in understanding
the ocular surface microbiome. Am J Ophthalmol. 2014;158:3.
26. Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol.
2011;9:244–253.
27. Kabara JJ. Lipids as host-resistance factors of human-milk. Nutr
Rev. 1980;38:65–73.
28. Kelsey JA, Bayles KW, Shafii B, McGuire MA. Fatty acids and
monoacylglycerols inhibit growth of Staphylococcus aureus.
Lipids. 2006;41:951–961.
29. Preuss HG, Echard B, Enig M, Brook I, Elliott TB. Minimum
inhibitory concentrations of herbal essential oils and mono-
laurin for gram-positive and gram-negative bacteria. Molec Cell
Biochem. 2005;272:29–34.
30. Drake DR, Brogden KA, Dawson DV, Wertz PW. Thematic
review series: Skin lipids—Antimicrobial lipids at the skin
surface. J Lipid Res. 2008;49:4–11.
31. Dougherty JM, McCulley JP. Analysis of the free fatty acid
component of meibomian secretions in chronic blepharitis.
Invest Ophthalmol Vis Sci. 1986;27:52–56.
32. Arita R, Mori N, Shirakawa R, et al. Meibum color and free fatty
acid composition in patients with meibomian gland dysfunc-
tion. Invest Ophthalmol Vis Sci. 2015;56:4403–4412.
33. Mates A. Inhibition by tetracycline in the occurrence of
extracellular lipase from Staphylococcus aureus. Microbios.
1973;7:25–29.
34. Mates A. Effect of eight tetracyclines on growth and lipase
formation of Staphylococcus aureus. Microbios. 1974;
10A(suppl):105–110.
35. Schlievert PM, Strandberg KL, Brosnahan AJ, et al. Glycerol
monolaurate does not alter Rhesus macaque (Macaca
mulatta) vaginal lactobacilli and is safe for chronic use.
Antimicrob Agents Chemother. 2008;52:4448–4454.
36. Peterson ML, Schlievert PM. Glycerol monolaurate inhibits the
effects of gram-positive select agents on eukaryotic cells.
Biochemistry. 2006;45:2387–2397.
37. Johnson W. Final report of the amended safety assessment of
glyceryl laurate, glyceryl laurate se, glyceryl laurate/oleate,
glyceryl adipate, glyceryl alginate, glyceryl arachidate, glyceryl
arachidonate, glyceryl behenate, glyceryl caprate, glyceryl
caprylate, glyceryl caprylate/caprate, glyceryl citrate/lactate/
linoleate/oleate, glyceryl cocoate, glyceryl collagenate, glycer-
yl erucate, glyceryl hydrogenated rosinate, glyceryl hydroge-
nated soyate, glyceryl hydroxystearate, glyceryl isopalmitate,
glyceryl isostearate, glyceryl isostearate/myristate, glyceryl
isostearates, glyceryl lanolate, glyceryl linoleate, glyceryl
linolenate, glyceryl montanate, glyceryl myristate, glyceryl
isotridecanoate/stearate/adipate, glyceryl oleate se, glyceryl
oleate/elaidate, glyceryl palmitate, glyceryl palmitate/stearate,
glyceryl palmitoleate, glyceryl pentadecanoate, glyceryl poly-
acrylate, glyceryl rosinate, glyceryl sesquioleate, glyceryl/
sorbitol oleate/hydroxystearate, glyceryl stearate/acetate, glyc-
eryl stearate/maleate, glyceryl tallowate, glyceryl thiopropio-
nate, and glyceryl undecylenate. Int J Toxicol. 2004;23(suppl
2):55–94.
38. Longshaw CM, Farrell AM, Wright JD, Holland KT. Identifica-
tion of a second lipase gene, Gehd, in Staphylococcus
epidermidis: Comparison of sequence with those of other
staphylococcal lipases. Microbiology. 2000;146(Pt 6):1419–
1427.
39. Rollof J, Braconier JH, Soderstrom C, Nilsson-Ehle P. Interfer-
ence of Staphylococcus aureus lipase with human granulocyte
function. Eur J Clin Microbiol Infect Dis. 1988;7:505–510.
40. Dave SB, Toma HS, Kim SJ. Changes in ocular flora in eyes
exposed to ophthalmic antibiotics. Ophthalmology. 2013;120:
937–941.
41. Andersen SB, Marvig RL, Molin S, Krogh Johansen H, Griffin
AS. long-term social dynamics drive loss of function in
pathogenic bacteria. Proc Natl Acad Sci U S A. 2015;112:
10756–10761.
42. Cheung GY, Wang R, Khan BA, Sturdevant DE, Otto M. Role of
the accessory gene regulator Agr in community-associated
methicillin-resistant Staphylococcus aureus pathogenesis.
Infect Immun. 2011;79:1927–1935.
43. Zhou Y, Holland MJ, Makalo P, et al. The conjunctival
microbiome in health and trachomatous disease: A case
control study. Genome Med. 2014;6:99.
44. Young JC, Pan C, Adams RM, et al. metaproteomics reveals
functional shifts in microbial and human proteins during a
preterm infant gut colonization case. Proteomics. 2015;15:
3463–3473.
45. Morowitz MJ, Denef VJ, Costello EK, et al. strain-resolved
community genomic analysis of gut microbial colonization in a
premature infant. Proc Natl Acad Sci U S A. 2011;108:1128–1133.
Glycerol Monolaurate Inhibits Bacterial Lipase Production IOVS j February 2016 j Vol. 57 j No. 2 j 550
Downloaded From: http://arvojournals.org/ on 06/13/2016
